Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-044724
Filing Date
2017-08-23
Accepted
2017-08-23 14:22:51
Documents
1
Period of Report
2017-08-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v473922_4.html 4  
1 OWNERSHIP DOCUMENT v473922_4.xml 4 3152
  Complete submission text file 0001144204-17-044724.txt   4918
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK NY 10158
Business Address
Yablonka Uri (Reporting) CIK: 0001608814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 171046868